You are here: Home > News > Detailed Guide Regarding the EudraVigilance Data Management Activities by the EMA
Detailed Guide Regarding the EudraVigilance Data Management Activities by the EMA
On 9 November 2020 the EMA announced the availability of the updated guide.
This document provides an overview of the data management and quality assurance activities performed by the EMA on information of suspected adverse reactions and medicinal products reported to and held in EudraVigilance and the XEVMPD.
